4.7 Article

GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

GCN5 acetyltransferase in cellular energetic and metabolic processes

Beste Mutlu et al.

Summary: GCN5, encoded by the mammalian gene Kat2a, is a histone acetyltransferase that plays a crucial role in regulating gene expression programs in response to cellular metabolic and energetic states. It functions as a nutrient sensor, linking histone acetylation to transcriptional activation, and also plays a significant role in energy metabolism by acetylating proteins like PGC-1 alpha.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2021)

Article Cardiac & Cardiovascular Systems

FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway

Xuejun Hui et al.

Summary: Pathological cardiac hypertrophy is a major cause of cardiac morbidity and mortality worldwide, and FBXW5 plays a crucial role in this process. Studies have shown that deficiency of FBXW5 exacerbates cardiac hypertrophy, while overexpression of FBXW5 protects against it.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

Article Cell Biology

KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer

Dingheng Lu et al.

Summary: Abiraterone, a novel androgen synthesis inhibitor, is approved for treating castration-resistant prostate cancer(CRPC). However, patients often develop resistance to it, and the role of Lysine acetyltransferase 2 A (KAT2A) in this resistance was investigated. Higher KAT2A expression was found in abiraterone-resistant prostate cancer cells and in patients with poor clinical outcomes. Knocking down KAT2A partially resensitized resistant cells to abiraterone, while overexpressing it promoted resistance. These findings suggest KAT2A as a potential target for CRPC treatment.

CELL DEATH & DISEASE (2021)

Article Biochemistry & Molecular Biology

DNA repair complex licenses acetylation of H2AZ1 by KAT2A during transcription

M. Semer et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Cell Biology

Gcn5-Mediated Histone Acetylation Governs Nucleosome Dynamics in Spermiogenesis

Lacey J. Luense et al.

DEVELOPMENTAL CELL (2019)

Article Cell Biology

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway

Hai-han Liao et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Cell & Tissue Engineering

A Linc1405/Eomes Complex Promotes Cardiac Mesoderm Specification and Cardiogenesis

Xudong Guo et al.

CELL STEM CELL (2018)

Article Cardiac & Cardiovascular Systems

Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development

Tushar K. Ghosh et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Mechanisms of physiological and pathological cardiac hypertrophy

Michinari Nakamura et al.

NATURE REVIEWS CARDIOLOGY (2018)

Review Biochemistry & Molecular Biology

Post-Translational Modifications of the TAK1-TAB Complex

Yusuke Hirata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Medicine, General & Internal

Heart failure

Marco Metra et al.

LANCET (2017)

Article Multidisciplinary Sciences

KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase

Yugang Wang et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

Chemical inhibition of the histone acetyltransferase activity in Arabidopsis thaliana

Felipe Aquea et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy

Zhihua Wang et al.

NATURE MEDICINE (2016)

Article Multidisciplinary Sciences

KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification

Marjorie Fournier et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling

Yan-Xiao Ji et al.

NATURE COMMUNICATIONS (2016)

Review Genetics & Heredity

Functions of SAGA in development and disease

Li Wang et al.

EPIGENOMICS (2014)

Review Immunology

Cell type-specific function of TAK1 in innate immune signaling

Adebusola A. Ajibade et al.

TRENDS IN IMMUNOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Interaction Between NFκB and NFAT Coordinates Cardiac Hypertrophy and Pathological Remodeling

Qinghang Liu et al.

CIRCULATION RESEARCH (2012)

Article Biochemistry & Molecular Biology

O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release

Shalini Pathak et al.

EMBO JOURNAL (2012)

Article Cell Biology

Roles for Gcn5 in promoting nucleosome assembly and maintaining genome integrity

Rebecca J. Burgess et al.

CELL CYCLE (2010)

Article Endocrinology & Metabolism

TAK1 Regulates Cartilage and Joint Development via the MAPK and BMP Signaling Pathways

Lea M. Gunnell et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Article Biochemistry & Molecular Biology

Acetylation by GCN5 regulates CDC6 phosphorylation in the S phase of the cell cycle

Roberta Paolinelli et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)

Article Multidisciplinary Sciences

Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPβ by GCN5

Nadine Wiper-Bergeron et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling

T Ishitani et al.

EMBO JOURNAL (2003)

Article History & Philosophy Of Science

Molecular mechanism of cardiac hypertrophy and development

I Komuro

JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION (2001)